Videos
-
Ensuring Efficient Operations
6/18/2026
In this segment from the Pharmaceutical Online Live event, “Analytical Strategies for High-Volume GLP-1 Manufacturing” our panelists talk about utilizing continuous manufacturing in GLP-1 production, how to use lean manufacturing and other tools to create an environment of operational excellence and modeling the process to simulate new parameters or ideas before integrating them.
-
Quantifying And Characterizing Impurities
6/18/2026
In this segment from the Pharmaceutical Online Live event, “Analytical Strategies for High-Volume GLP-1 Manufacturing” our panelists talk about quantifying and characterizing your impurities. They discuss two levels of LC-MS in the future for better impurity profiling, including 2D LC-MS.
-
Reducing Release Timelines
6/18/2026
In this segment from the Pharmaceutical Online Live event, “Analytical Strategies for High-Volume GLP-1 Manufacturing” our panelists talk about reducing release timelines with NIR spectrophotometry, the biggest bottlenecks to release testing, AI assisting in release testing and how companies are approaching real time release testing.
-
Starting Material Importance
6/18/2026
In this segment from the Pharmaceutical Online Live event, “Analytical Strategies for High-Volume GLP-1 Manufacturing” our panelists talk about the element of GLP-1 manufacturing received the least attention but is the most important operationally—the starting material.
-
Adjusting Monitoring And Sampling Methods
6/18/2026
In this segment from the Pharmaceutical Online Live event, “Analytical Strategies for High-Volume GLP-1 Manufacturing” our panelists discuss adjustment to analytical strategies in increased GLP-1 manufacturing such as monitoring for aggregates, changing sampling rates, NIR spectrophotometry, reducing human interaction, and how analytical throughput changes from injectable peptides to oral peptides.
-
Analyzing Risk And Ensuring Quality
6/18/2026
In this segment from the Pharmaceutical Online Live event, “Analytical Strategies for High-Volume GLP-1 Manufacturing” our panelists talk about quality control, including ensuring a quality by design process, optimizing risk analysis, and continuous improvement.
-
High-Volume GLP-1 Manufacturing: Challenges And Bottlenecks On A Global Scale
6/18/2026
In this segment from the Pharmaceutical Online Live event, “Analytical Strategies for High-Volume GLP-1 Manufacturing,” the panelists discuss the issues with variability that can arise with scale-up to multi-tonne quantities, the surprises that came with a high global demand and the biggest bottlenecks to scale-up.
-
Adaptations To The Process And Scale-up
10/29/2025
In this segment from the Pharmaceutical Online Live event, “Balancing GLP-1 Quality With Demand,” our panelists discuss changes to the process and the importance of the change control process to track the results of these changes but also to evaluate the impact of the change. The panelists also jump into batch versus continuous processing and talk about the bottlenecks in scale-up.
-
Quality Control Failures And Solutions
10/29/2025
In this segment from the Pharmaceutical Online Live event, “Balancing GLP-1 Quality With Demand,” our panelists talk about common quality control failures, preventing them with the right analytical methods, and investing enough time and resources in quality control to ensure problems don’t arise.
-
Answering The Demand And Innovation
10/29/2025
In this segment from the Pharmaceutical Online Live event, “Balancing GLP-1 Quality With Demand,” the panelists discuss how the market has shifted to answer the growing demand for GLP-1 analogs and how innovations in delivery, manufacturing processes and peptide synthesis have helped to aid the demand.